Partner at Kirkland & Ellis LLP
Daniel Lim is a partner in Kirkland’s IP litigation team in London. Mr Lim has a broad practice that covers a wide range of technical fields, but is particularly noted for his expertise in life sciences patent litigation, particularly in the pharmaceutical industry, diagnostics and the emerging fields of precision medicine and cell and gene therapy. He is also experienced in representing clients involved in complex standard-essential patent and FRAND licensing disputes.
In addition to UK litigation, Mr Lim is frequently called upon to assist clients in devising, coordinating and executing patent strategies for complex multi-jurisdictional disputes on a pan-European and global scale. With dual qualifications in law and biochemistry, and experience litigating in multiple jurisdictions around the world, Mr Lim is readily able to grasp highly technical material and the international dimensions of disputes which are often at the heart of effective strategies in blockbuster litigation for the most sophisticated clients.
A strong believer in the power of scientific innovation in healthcare and medicine to improve clinical outcomes and quality of life, and the role of intellectual property in incentivising and protecting innovation, Mr Lim often represents leading companies for whom such innovation is core to their business.
Mr Lim is recognised as a thought leader and frequent writer, speaker and commentator on a wide range of topics relating to the life sciences industry and intellectual property generally, notably including the rising gene-editing technology CRISPR. Testament to his standing and leadership in the IP community, Mr Lim currently serves as vice chair of two standing committees of the International Association for the Protection of Intellectual Property – namely, the Biotechnology Standing Committee, and the IP and Genetic Resources/Traditional Knowledge Standing Committee.
Mr Lim is listed in IAM Patent 1000, IAM Strategy 300 and WIPR Leaders (2020), and has been recognised as a “Rising Star in IP” by Managing Intellectual Property (2017 and 2018), “Rising Star in Life Sciences” by Expert Guides (2019) and “Rising Star” in the life sciences and UK categories at Euromoney LMG’s Europe Rising Stars Awards 2019.